1 / 10

The Technological Network on HIV/AIDS Milestones and Achievements

The Technological Network on HIV/AIDS Milestones and Achievements. Cristina d´Almeida Executive Secretary. Milestones. 2003. UNGASS, New York (September) - Brazil, South Africa and India decided to gather efforts to promote technological self-sufficiency on HIV/AIDS

kato-blanchard
Télécharger la présentation

The Technological Network on HIV/AIDS Milestones and Achievements

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Technological Network on HIV/AIDSMilestones and Achievements Cristina d´Almeida Executive Secretary

  2. Milestones 2003 • UNGASS, New York (September) - Brazil, South Africa and India decided to gather efforts to promote technological self-sufficiency on HIV/AIDS • Interest of other developing countries (China, Nigeria and Russia) in joining this initiative • XV International Aids Conference, Bangkok (July)- Signature of the Joint Declaration of Commitments amongst 6 developing countries on the scope of the fight against HIV/AIDS (Brazil, China, Nigeria, Russia, Ukraine and Thailand) 2004 2005 • 1st Round of the Technological Network on HIV/AIDS, Rio de Janeiro (January) • 58th World Health Assembly, Geneva, (May)– Endorsement of the Joint Declaration establishing the Technological Network on HIV/AIDS • 1st Workshop in API Synthesis and ARV Formulation, Shanghai (August)

  3. Objectives • Transfer of technology: (i) synthesis of active pharmaceutical ingredients (ii) ARV manufacturing (iii) laboratory kitsR&D • Establishment of Agreements on technical-scientific cooperation with a view to strengthen capacity building • Implementation of Joint initiatives directed to HIV vaccines development, including basic research, clinical trials, and production itself • Legal Technical Assistance related to sanitary surveillance of HIV/AIDS products and Intellectual Property Management

  4. Network’s Key Players • Member Countries (delegations) • Focal Point (political representation) • Technical experts (R&D, manufacturing) • Research Institutions (Cooperation partners) • Executive Secretariat • Observers • External partners (WHO, ANRS, UNDP)

  5. Country Members • Argentina • Brazil • China • Cuba • Nigeria • Russia • Thailand • Ukraine • Uruguay (observer)

  6. Donnors • Ford Foundation – US$ 1 million, until March 2007 • UNDP – support to the 2nd Round • Brazilian STD/AIDS Program

  7. Achievements • Rules of Procedure • Establishment of member countries´ criteria • Definition of the Network´s objectives • Definition of commons commitments on Intellectual Property and Quality Control • Cooperation Agenda • Definition of the main technological areas and activites for technical cooperation: • API synthesis, ARV formulation, R&D in laboratory technologies, manufacturing of condoms, R&D on vaccines and microbicides • First Technical Cooperations on API synthesis and ARV formulation • Technical Assess Study on Pharmaceutical Productive Capacity of Developing Countries (UNDP)

  8. Technical Cooperation on API synthesisand ARV formulation (Shanghai, Sept 2005)

  9. Technical Cooperation Proposals on Quality Assurance (Cuba, June 2006) • Assessment on quality assurance related to HIV/AIDS LAB to assess the state-of-the art of each country (two experts working on a consultancy basis visiting each member country in order to do the assessment. It may be necessary to use other more cost-effective strategies to gather information). To implement a data bank initiative related to LAB issues based on WHO´s and other existing initiatives • To implement a reference panel sample bank • To review existing guidelines documents related to quality assurance in order to make a joint proposal document regarding all HIV/AIDS Laboratory QC (EIA, Rapid tests, VL, CD4) • To define a training strategy related to the assessed issues • A similar assessment on antiretroviral QC issues

  10. Next Steps

More Related